Welcome to our dedicated page for Balchem news (Ticker: BCPC), a resource for investors and traders seeking the latest updates and insights on Balchem stock.
Balchem Corp (BCPC) delivers specialty performance ingredients for nutrition and industrial markets through advanced technologies. This news hub provides investors and industry professionals with essential updates on corporate developments and market leadership.
Access authoritative reporting on earnings announcements, product innovations, and strategic partnerships. Our curated collection ensures you stay informed about BCPC's advancements in microencapsulation techniques and chelation technology across human/animal nutrition sectors.
Discover press releases detailing regulatory milestones, manufacturing expansions, and sustainability initiatives. All content is verified for accuracy, offering neutral analysis without speculative commentary.
Bookmark this page for real-time access to Balchem's financial disclosures and operational updates. Regularly refreshed content supports informed decision-making for stakeholders tracking specialty chemical markets.
Balchem Corporation (NASDAQ: BCPC) reported record third quarter net earnings of $25 million for 2021, up from $21.6 million in Q3 2020. Adjusted net earnings reached $30 million, a rise of 11.3%, and net sales were $197.9 million, reflecting a 13% increase. Each business segment reported record sales, driven by strong performance in Human Nutrition & Health and Animal Nutrition & Health. Adjusted EBITDA improved to $48.3 million, an 8.8% increase. Cash flows from operations were $39.6 million, with free cash flow at $31.1 million, demonstrating robust financial health amidst economic challenges.
Balchem Corporation (NASDAQ: BCPC) will hold a conference call on October 29, 2021, at 11:00 AM ET to discuss its third quarter results. The results will be released before the market opens on the same day. Participants can access the call by dialing 1-877-407-8289 (local 1-201-689-8341) five minutes prior to the start. A replay of the call will be available until November 12, 2021. Balchem specializes in nutritional ingredients across multiple sectors including animal and human health.
Balchem Corporation (NASDAQ: BCPC) reported record second quarter net earnings of $22.7 million for 2021, a 7.6% increase from $21.1 million in Q2 2020. Adjusted net earnings rose to $30.4 million, up 10.3%. Net sales reached $202.4 million, a 16.7% increase driven by growth in all segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. Despite experiencing a $3.8 million loss from a flash flood event, cash flows remained strong with $35.8 million from operations. The effective tax rate increased to 24.3% from 18.7% in the prior year.
Balchem Corporation (NASDAQ: BCPC) is set to present at the Jefferies Virtual Industrials Conference on August 4, 2021, starting at 9:00 a.m. ET. The presentation will be led by Chairman and CEO Ted Harris, along with CFO Martin Bengtsson. Investors and interested parties can listen to the presentation via the provided link.
Balchem specializes in developing, manufacturing, and marketing ingredients aimed at improving health across various industries, including Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) will hold a conference call on July 30, 2021, at 11:00 AM ET to discuss its second quarter results. The results will be published before the market opens on the same day. The conference call, hosted by Ted Harris (CEO) and Martin Bengtsson (CFO), will be available for replay until August 13, 2021. Interested parties can access the call by dialing toll-free 1-877-407-8289. More details including financial exhibits will be available on balchem.com.
Balchem Corporation (NASDAQ: BCPC) will present at the Stephens Food & Ag Disrupted: Public-Private Conference on May 25, 2021, starting at 9:00 a.m. (ET). Chairman and CEO Ted Harris and CFO Martin Bengtsson will lead the presentation. Investors can follow the link to listen live: Presentation Link.
Balchem develops specialty ingredients across three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, enhancing health and well-being globally.
Balchem Corporation (NASDAQ: BCPC) reported strong first-quarter 2021 financial results, achieving net earnings of $23.4 million, up 18.4% year-over-year. Adjusted net earnings also rose to $28.4 million, reflecting growth across all three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. Net sales increased by 6.4% to $185.7 million, with notable contributions from chelated minerals and choline nutrients. The company maintained strong cash flow, leading to $40.6 million in operational cash flow and $34.4 million in free cash flow.
Balchem Corporation (NASDAQ: BCPC) announced a conference call scheduled for April 30, 2021, at 11:00 AM ET to discuss its first quarter results. The financial results will be released before the market opens on the same day. Attendees can join the call by dialing a toll-free number and access a replay through specified numbers until May 14, 2021. Balchem operates in three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, focusing on enhancing health and well-being.
Balchem Corporation (NASDAQ: BCPC) will present at the J.P. Morgan Industrials Conference on March 15, 2021. CEO Ted Harris and CFO Martin Bengtsson will lead the presentation, starting at 9:40 a.m. ET. Interested parties can follow the provided link to listen live.
Balchem specializes in developing and marketing ingredients that enhance health and well-being across various industries. Their operations are divided into three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
FAQ
What is the current stock price of Balchem (BCPC)?
What is the market cap of Balchem (BCPC)?
